Editable Qualification Protocol
A Word framework covering prerequisites, qualification families, challenge-set governance, execution, performance, failures, requalification, records, and approvals.
Editable Qualification Resource
Build a controlled qualification system—not just a passing score—with an editable protocol, challenge-set controls, trial records, transparent performance calculations, remediation, and requalification planning.
Contact information is required. Files are released immediately after submission.
Release 1.0
What You Receive
The toolkit connects the protocol, challenge-set answer key, raw candidate decisions, performance calculations, qualification status, failure response, and requalification schedule. It deliberately leaves site criteria blank until they are scientifically justified and approved.
A Word framework covering prerequisites, qualification families, challenge-set governance, execution, performance, failures, requalification, records, and approvals.
Linked tools for decisions, candidates, eligibility, challenge sets, blinded trials, performance, remediation, due dates, and audit readiness.
A primary-source register and decision fields that separate requirements, GMP expectations, draft recommendations, technical practices, and site choices.
Designed to Prevent False Certainty
Qualification depends on the actual product, package, inspection method, defect population, jurisdiction, and quality system. The toolkit therefore makes assumptions and approval points explicit rather than hiding them behind generic numbers.
Important limitation
The files are not an approved protocol, compliance guarantee, medical assessment, or automatic certification decision. Your organization must validate formulas and electronic controls before GMP use.
No universal pass score
Your organization defines and approves metrics, thresholds, baseline methods, and statistical rationale.
No automatic 20/20 rule
The toolkit records the site-approved eligibility outcome without presenting one eyesight threshold as universally required.
No repeat-until-pass
Failures move through status control, investigation, targeted remediation, authorization, and documented re-entry.
No one-size-fits-all test set
Set size, defect ratio, representativeness, trials, masking, and worst-case conditions remain controlled site decisions.
Source Control
The toolkit distinguishes binding U.S. CGMP, EU GMP and WHO expectations, FDA’s nonbinding December 2021 draft guidance, informational USP principles, and industry technical approaches. It also explains why familiar numbers such as a single pass score or fixed test-set size should not be presented as universal requirements.
EU GMP Annex 1 and WHO TRS 1044 call for at-least-annual manual visual inspection qualification where applicable. U.S. CGMP requires continuing training but does not itself create the same universal annual interval. The toolkit keeps that distinction explicit.
Qualification Questions
These answers distinguish applicable requirements from draft recommendations and site-defined qualification decisions.
No. Metrics, thresholds, baseline methods, and statistical rationale should be defined and approved for the actual product, package, inspection method, defect population, and applicable market. The workbook leaves those cells blank until your organization enters approved criteria.
The cited sources do not establish one universal 20/20 threshold for every program. FDA draft guidance recommends normal near visual acuity with or without corrective lenses; EU GMP Annex 1 and WHO TRS 1044 call for normally worn corrective lenses and consideration of eyesight checks.
There is no single universal set size in the cited requirements. The organization should justify the number of units, defect proportion and distribution, detectability range, trials, masking, randomization, and confidence. FDA draft guidance recommends that defective units typically not exceed 10–20%, but that recommendation is nonbinding.
EU GMP Annex 1 and WHO TRS 1044 state at least annually. U.S. CGMP requires continuing training at sufficient frequency, while FDA draft guidance recommends periodic retraining or requalification as appropriate; the U.S. regulation itself does not prescribe the same universal annual interval.
Implementation Reading
Put It Into Practice
Define qualification families, methods, criteria, lifecycle controls, and documentation for your actual products and inspection process.
Learn moreDevelop representative defect standards for training, qualification, method evaluation, and lifecycle maintenance.
Learn moreAddress formulation and package characteristics that affect defect visibility, presentation, and qualification scope.
Learn more